▶ 調査レポート

低侵襲手術の世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Minimally Invasive Surgery Market (Procedure: Laparoscopic Surgery, Robotic Surgery, Endoscopic Mucosal Resection, Endoscopic Submucosal Dissection, and Transcatheter) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが調査・発行した産業分析レポートです。低侵襲手術の世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測 / Minimally Invasive Surgery Market (Procedure: Laparoscopic Surgery, Robotic Surgery, Endoscopic Mucosal Resection, Endoscopic Submucosal Dissection, and Transcatheter) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 / MRC2207A083資料のイメージです。• レポートコード:MRC2207A083
• 出版社/出版日:Transparency Market Research / 2022年5月
• レポート形態:英文、PDF、179ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥764,940 (USD5,795)▷ お問い合わせ
  Multi User¥1,160,940 (USD8,795)▷ お問い合わせ
  Corporate License¥1,556,940 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
トランスペアレンシー・マーケット・リサーチ社の本調査レポートでは、世界の低侵襲手術市場について総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、処置別(腹腔鏡手術、ロボット手術、内視鏡的粘膜切除術、内視鏡的粘膜下層剥離術、経カテーテル)分析、疾患別分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの内容をまとめております。なお、本書に掲載されている企業情報にはApollo Hospitals Enterprise Limited、Huntington Hospital、Johns Hopkins Hospital、Massachusetts General Hospital、Rutland Medical Center、Saint Michael's Hospital、Singapore General Hospital、The Ottawa Hospital、University of Pittsburgh Medical Center、Washington Hospital Healthcare Systemなどが含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界の低侵襲手術市場規模:処置別(腹腔鏡手術、ロボット手術、内視鏡的粘膜切除術、内視鏡的粘膜下層剥離術、経カテーテル)
・世界の低侵襲手術市場規模:疾患別
・世界の低侵襲手術市場規模:エンドユーザー別
・世界の低侵襲手術市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Minimally Invasive Surgery Market – Scope of Report

TMR’s report on the global minimally invasive surgery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global minimally invasive surgery market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global minimally invasive surgery market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the minimally invasive surgery market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global minimally invasive surgery market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global minimally invasive surgery market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global minimally invasive surgery market.

The report delves into the competitive landscape of the global minimally invasive surgery market. Key players operating in the global minimally invasive surgery market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global minimally invasive surgery market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market minimally invasive surgery.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Minimally Invasive Surgery Market
4. Market Overview
4.1. Overview
4.2. Market Dynamics, by Region
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
5. Key Insights
5.1. Overview of reimbursement scenario for MIS surgeries by Region
5.1.1. Reimbursement Trends
5.2. Overview of pricing of MIS products
5.3. Data related to percentage of MIS adoption as compared to total procedures
5.4. Comparison between MIS and Open Surgery (Volume, by Region)
5.5. Information related MIS Training
5.6. 1 MIS Training Gap
6. Verbatim about Training
6.1. Number of surgeons in each medical specialty and how many of them use MIS today (as per best-efforts basis)
6.2. List of procedures that can be done by MIS for each specialty
6.3. Cost of Surgery in Different Countries
6.4. Major Hospitals, by Region/Country
6.5. COVID-19 Impact Analysis
7. Global Minimally Invasive Surgery Market Analysis and Forecast, by Procedure
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017–2031
7.3.1. Laparoscopic Surgery
7.3.1.1. Orthopedic Surgery
7.3.1.2. Thoracic Surgery
7.3.1.3. Urology Surgery
7.3.1.4. Gynecology Surgery
7.3.1.5. Vascular Surgery
7.3.1.6. General Surgery
7.3.1.7. Cancer Surgery
7.3.1.8. Breast Surgery
7.3.1.9. Ear, Nose, and Throat Surgery
7.3.1.10. Bariatric Surgery
7.3.2. Robotic Surgery
7.3.2.1. Orthopedic Surgery
7.3.2.2. Cardiac Surgery
7.3.2.3. Thoracic Surgery
7.3.2.4. Urology Surgery
7.3.2.5. Gynecology Surgery
7.3.2.6. Vascular Surgery
7.3.2.7. General Surgery
7.3.2.8. Cancer Surgery
7.3.2.9. Breast Surgery
7.3.2.10. Ear, Nose, and Throat Surgery
7.3.2.11. Bariatric Surgery
7.3.2.12. Cosmetic/Plastic Surgery
7.3.2.13. Neurosurgery
7.3.3. Endoscopic Mucosal Resection
7.3.3.1. Thoracic Surgery
7.3.3.2. General Surgery
7.3.3.3. Cancer Surgery
7.3.3.4. Bariatric Surgery
7.3.4. Endoscopic Submucosal Dissection
7.3.4.1. General Surgery
7.3.4.2. Cancer Surgery
7.3.4.3. Bariatric Surgery
7.3.5. Transcatheter
7.3.5.1. Cardiac Surgery
7.3.5.2. Vascular Surgery
7.3.5.3. Cancer Surgery
7.3.5.4. Bariatric Surgery
7.4. Global Minimally Invasive Surgery Market Attractiveness, by Procedure
8. Global Minimally Invasive Surgery Market Analysis and Forecast, by Disease Indication
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017–2031
8.3.1. Orthopedic Surgery
8.3.1.1. Knee
8.3.1.2. Spine
8.3.1.3. Shoulder
8.3.1.4. Others
8.3.2. Cardiac Surgery
8.3.2.1. Mitral Valve
8.3.2.2. Aortic Valve
8.3.2.3. Structural Heart Disease
8.3.2.4. Tricuspid Valve
8.3.2.5. Others
8.3.3. General Surgery
8.3.3.1. Gastrointestinal Surgery
8.3.3.2. Hepatobiliary Pancreatic Surgery
8.3.4. Urology Surgery
8.3.5. Thoracic Surgery
8.3.6. Gynecology Surgery
8.3.7. Vascular Surgery
8.3.8. Cancer Surgery
8.3.9. Breast Surgery
8.3.10. Ear, Nose, and Throat Surgery
8.3.11. Bariatric Surgery
8.3.12. Cosmetic/Plastic Surgery
8.3.13. Neurosurgery
8.4. Global Minimally Invasive Surgery Market Attractiveness, by Disease Indication
9. Global Minimally Invasive Surgery Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Minimally Invasive Surgery Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.1.1. Orthopedic Surgery
9.3.1.2. Cardiac Surgery
9.3.1.3. Thoracic Surgery
9.3.1.4. Urology Surgery
9.3.1.5. Gynecology Surgery
9.3.1.6. Vascular Surgery
9.3.1.7. General Surgery
9.3.1.8. Cancer Surgery
9.3.1.9. Breast Surgery
9.3.1.10. Ear, Nose, and Throat Surgery
9.3.1.11. Bariatric Surgery
9.3.1.12. Cosmetic/Plastic Surgery
9.3.1.13. Neurosurgery
9.3.2. Clinics
9.3.2.1. Orthopedic Surgery
9.3.2.2. Cardiac Surgery
9.3.2.3. Thoracic Surgery
9.3.2.4. Urology Surgery
9.3.2.5. Gynecology Surgery
9.3.2.6. Vascular Surgery
9.3.2.7. General Surgery
9.3.2.8. Cancer Surgery
9.3.2.9. Breast Surgery
9.3.2.10. Ear, Nose, and Throat Surgery
9.3.2.11. Bariatric Surgery
9.3.2.12. Cosmetic/Plastic Surgery
9.3.2.13. Neurosurgery
9.3.3. Ambulatory Surgical Centers
9.3.3.1. Orthopedic Surgery
9.3.3.2. Cardiac Surgery
9.3.3.3. Thoracic Surgery
9.3.3.4. Urology Surgery
9.3.3.5. Gynecology Surgery
9.3.3.6. Vascular Surgery
9.3.3.7. General Surgery
9.3.3.8. Cancer Surgery
9.3.3.9. Breast Surgery
9.3.3.10. Ear, Nose, and Throat Surgery
9.3.3.11. Bariatric Surgery
9.3.3.12. Cosmetic/Plastic Surgery
9.3.3.13. Neurosurgery
9.3.4. Others
9.3.4.1. Orthopedic Surgery
9.3.4.2. Cardiac Surgery
9.3.4.3. Thoracic Surgery
9.3.4.4. Urology Surgery
9.3.4.5. Gynecology Surgery
9.3.4.6. Vascular Surgery
9.3.4.7. General Surgery
9.3.4.8. Cancer Surgery
9.3.4.9. Breast Surgery
9.3.4.10. Ear, Nose, and Throat Surgery
9.3.4.11. Bariatric Surgery
9.3.4.12. Cosmetic/Plastic Surgery
9.3.4.13. Neurosurgery
9.4. Global Minimally Invasive Surgery Market Attractiveness, by End-user
10. Global Minimally Invasive Surgery Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Minimally Invasive Surgery Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Minimally Invasive Surgery Market Attractiveness, by Region
11. North America Minimally Invasive Surgery Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017–2031
11.2.1. Laparoscopic Surgery
11.2.1.1. Orthopedic Surgery
11.2.1.2. Thoracic Surgery
11.2.1.3. Urology Surgery
11.2.1.4. Gynecology Surgery
11.2.1.5. Vascular Surgery
11.2.1.6. General Surgery
11.2.1.7. Cancer Surgery
11.2.1.8. Breast Surgery
11.2.1.9. Ear, Nose, and Throat Surgery
11.2.1.10. Bariatric Surgery
11.2.2. Robotic Surgery
11.2.2.1. Orthopedic Surgery
11.2.2.2. Cardiac Surgery
11.2.2.3. Thoracic Surgery
11.2.2.4. Urology Surgery
11.2.2.5. Gynecology Surgery
11.2.2.6. Vascular Surgery
11.2.2.7. General Surgery
11.2.2.8. Cancer Surgery
11.2.2.9. Breast Surgery
11.2.2.10. Ear, Nose, and Throat Surgery
11.2.2.11. Bariatric Surgery
11.2.2.12. Cosmetic/Plastic Surgery
11.2.2.13. Neurosurgery
11.2.3. Endoscopic Mucosal Resection
11.2.3.1. Thoracic Surgery
11.2.3.2. General Surgery
11.2.3.3. Cancer Surgery
11.2.3.4. Bariatric Surgery
11.2.4. Endoscopic Submucosal Dissection
11.2.4.1. General Surgery
11.2.4.2. Cancer Surgery
11.2.4.3. Bariatric Surgery
11.2.5. Transcatheter
11.2.5.1. Cardiac Surgery
11.2.5.2. Vascular Surgery
11.2.5.3. Cancer Surgery
11.2.5.4. Bariatric Surgery
11.3. North America Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017–2031
11.3.1. Orthopedic Surgery
11.3.1.1. Knee
11.3.1.2. Spine
11.3.1.3. Shoulder
11.3.1.4. Others
11.3.2. Cardiac Surgery
11.3.2.1. Mitral Valve
11.3.2.2. Aortic Valve
11.3.2.3. Structural Heart Disease
11.3.2.4. Tricuspid Valve
11.3.2.5. Others
11.3.3. General Surgery
11.3.3.1. Gastrointestinal Surgery
11.3.3.2. Hepatobiliary Pancreatic Surgery
11.3.4. Urology Surgery
11.3.5. Thoracic Surgery
11.3.6. Gynecology Surgery
11.3.7. Vascular Surgery
11.3.8. Cancer Surgery
11.3.9. Breast Surgery
11.3.10. Ear, Nose, and Throat Surgery
11.3.11. Bariatric Surgery
11.3.12. Cosmetic/Plastic Surgery
11.3.13. Neurosurgery
11.4. North America Minimally Invasive Surgery Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.1.1. Orthopedic Surgery
11.4.1.2. Cardiac Surgery
11.4.1.3. Thoracic Surgery
11.4.1.4. Urology Surgery
11.4.1.5. Gynecology Surgery
11.4.1.6. Vascular Surgery
11.4.1.7. General Surgery
11.4.1.8. Cancer Surgery
11.4.1.9. Breast Surgery
11.4.1.10. Ear, Nose, and Throat Surgery
11.4.1.11. Bariatric Surgery
11.4.1.12. Cosmetic/Plastic Surgery
11.4.1.13. Neurosurgery
11.4.2. Clinics
11.4.2.1. Orthopedic Surgery
11.4.2.2. Cardiac Surgery
11.4.2.3. Thoracic Surgery
11.4.2.4. Urology Surgery
11.4.2.5. Gynecology Surgery
11.4.2.6. Vascular Surgery
11.4.2.7. General Surgery
11.4.2.8. Cancer Surgery
11.4.2.9. Breast Surgery
11.4.2.10. Ear, Nose, and Throat Surgery
11.4.2.11. Bariatric Surgery
11.4.2.12. Cosmetic/Plastic Surgery
11.4.2.13. Neurosurgery
11.4.3. Ambulatory Surgical Centers
11.4.3.1. Orthopedic Surgery
11.4.3.2. Cardiac Surgery
11.4.3.3. Thoracic Surgery
11.4.3.4. Urology Surgery
11.4.3.5. Gynecology Surgery
11.4.3.6. Vascular Surgery
11.4.3.7. General Surgery
11.4.3.8. Cancer Surgery
11.4.3.9. Breast Surgery
11.4.3.10. Ear, Nose, and Throat Surgery
11.4.3.11. Bariatric Surgery
11.4.3.12. Cosmetic/Plastic Surgery
11.4.3.13. Neurosurgery
11.4.4. Others
11.4.4.1. Orthopedic Surgery
11.4.4.2. Cardiac Surgery
11.4.4.3. Thoracic Surgery
11.4.4.4. Urology Surgery
11.4.4.5. Gynecology Surgery
11.4.4.6. Vascular Surgery
11.4.4.7. General Surgery
11.4.4.8. Cancer Surgery
11.4.4.9. Breast Surgery
11.4.4.10. Ear, Nose, and Throat Surgery
11.4.4.11. Bariatric Surgery
11.4.4.12. Cosmetic/Plastic Surgery
11.4.4.13. Neurosurgery
11.5. North America Minimally Invasive Surgery Market Value Forecast, by Country, 2017–2031
11.5.1. U.S.
11.5.2. Canada
11.6. North America Minimally Invasive Surgery Market Attractiveness Analysis
11.6.1. By Procedure
11.6.2. By Disease Indication
11.6.3. By End-user
11.6.4. By Country
12. Europe Minimally Invasive Surgery Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017–2031
12.2.1. Laparoscopic Surgery
12.2.1.1. Orthopedic Surgery
12.2.1.2. Thoracic Surgery
12.2.1.3. Urology Surgery
12.2.1.4. Gynecology Surgery
12.2.1.5. Vascular Surgery
12.2.1.6. General Surgery
12.2.1.7. Cancer Surgery
12.2.1.8. Breast Surgery
12.2.1.9. Ear, Nose, and Throat Surgery
12.2.1.10. Bariatric Surgery
12.2.2. Robotic Surgery
12.2.2.1. Orthopedic Surgery
12.2.2.2. Cardiac Surgery
12.2.2.3. Thoracic Surgery
12.2.2.4. Urology Surgery
12.2.2.5. Gynecology Surgery
12.2.2.6. Vascular Surgery
12.2.2.7. General Surgery
12.2.2.8. Cancer Surgery
12.2.2.9. Breast Surgery
12.2.2.10. Ear, Nose, and Throat Surgery
12.2.2.11. Bariatric Surgery
12.2.2.12. Cosmetic/Plastic Surgery
12.2.2.13. Neurosurgery
12.2.3. Endoscopic Mucosal Resection
12.2.3.1. Thoracic Surgery
12.2.3.2. General Surgery
12.2.3.3. Cancer Surgery
12.2.3.4. Bariatric Surgery
12.2.4. Endoscopic Submucosal Dissection
12.2.4.1. General Surgery
12.2.4.2. Cancer Surgery
12.2.4.3. Bariatric Surgery
12.2.5. Transcatheter
12.2.5.1. Cardiac Surgery
12.2.5.2. Vascular Surgery
12.2.5.3. Cancer Surgery
12.2.5.4. Bariatric Surgery
12.3. Europe Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017–2031
12.3.1. Orthopedic Surgery
12.3.1.1. Knee
12.3.1.2. Spine
12.3.1.3. Shoulder
12.3.1.4. Others
12.3.2. Cardiac Surgery
12.3.2.1. Mitral Valve
12.3.2.2. Aortic Valve
12.3.2.3. Structural Heart Disease
12.3.2.4. Tricuspid Valve
12.3.2.5. Others
12.3.3. General Surgery
12.3.3.1. Gastrointestinal Surgery
12.3.3.2. Hepatobiliary Pancreatic Surgery
12.3.4. Urology Surgery
12.3.5. Thoracic Surgery
12.3.6. Gynecology Surgery
12.3.7. Vascular Surgery
12.3.8. Cancer Surgery
12.3.9. Breast Surgery
12.3.10. Ear, Nose, and Throat Surgery
12.3.11. Bariatric Surgery
12.3.12. Cosmetic/Plastic Surgery
12.3.13. Neurosurgery
12.4. Europe Minimally Invasive Surgery Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.1.1. Orthopedic Surgery
12.4.1.2. Cardiac Surgery
12.4.1.3. Thoracic Surgery
12.4.1.4. Urology Surgery
12.4.1.5. Gynecology Surgery
12.4.1.6. Vascular Surgery
12.4.1.7. General Surgery
12.4.1.8. Cancer Surgery
12.4.1.9. Breast Surgery
12.4.1.10. Ear, Nose, and Throat Surgery
12.4.1.11. Bariatric Surgery
12.4.1.12. Cosmetic/Plastic Surgery
12.4.1.13. Neurosurgery
12.4.2. Clinics
12.4.2.1. Orthopedic Surgery
12.4.2.2. Cardiac Surgery
12.4.2.3. Thoracic Surgery
12.4.2.4. Urology Surgery
12.4.2.5. Gynecology Surgery
12.4.2.6. Vascular Surgery
12.4.2.7. General Surgery
12.4.2.8. Cancer Surgery
12.4.2.9. Breast Surgery
12.4.2.10. Ear, Nose, and Throat Surgery
12.4.2.11. Bariatric Surgery
12.4.2.12. Cosmetic/Plastic Surgery
12.4.2.13. Neurosurgery
12.4.3. Ambulatory Surgical Centers
12.4.3.1. Orthopedic Surgery
12.4.3.2. Cardiac Surgery
12.4.3.3. Thoracic Surgery
12.4.3.4. Urology Surgery
12.4.3.5. Gynecology Surgery
12.4.3.6. Vascular Surgery
12.4.3.7. General Surgery
12.4.3.8. Cancer Surgery
12.4.3.9. Breast Surgery
12.4.3.10. Ear, Nose, and Throat Surgery
12.4.3.11. Bariatric Surgery
12.4.3.12. Cosmetic/Plastic Surgery
12.4.3.13. Neurosurgery
12.4.4. Others
12.4.4.1. Orthopedic Surgery
12.4.4.2. Cardiac Surgery
12.4.4.3. Thoracic Surgery
12.4.4.4. Urology Surgery
12.4.4.5. Gynecology Surgery
12.4.4.6. Vascular Surgery
12.4.4.7. General Surgery
12.4.4.8. Cancer Surgery
12.4.4.9. Breast Surgery
12.4.4.10. Ear, Nose, and Throat Surgery
12.4.4.11. Bariatric Surgery
12.4.4.12. Cosmetic/Plastic Surgery
12.4.4.13. Neurosurgery
12.5. Europe Minimally Invasive Surgery Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. Germany
12.5.2. U.K.
12.5.3. France
12.5.4. Italy
12.5.5. Spain
12.5.6. Rest of Europe
12.6. Europe Minimally Invasive Surgery Market Attractiveness Analysis
12.6.1. By Procedure
12.6.2. By Disease Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Asia Pacific Minimally Invasive Surgery Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017–2031
13.2.1. Laparoscopic Surgery
13.2.1.1. Orthopedic Surgery
13.2.1.2. Thoracic Surgery
13.2.1.3. Urology Surgery
13.2.1.4. Gynecology Surgery
13.2.1.5. Vascular Surgery
13.2.1.6. General Surgery
13.2.1.7. Cancer Surgery
13.2.1.8. Breast Surgery
13.2.1.9. Ear, Nose, and Throat Surgery
13.2.1.10. Bariatric Surgery
13.2.2. Robotic Surgery
13.2.2.1. Orthopedic Surgery
13.2.2.2. Cardiac Surgery
13.2.2.3. Thoracic Surgery
13.2.2.4. Urology Surgery
13.2.2.5. Gynecology Surgery
13.2.2.6. Vascular Surgery
13.2.2.7. General Surgery
13.2.2.8. Cancer Surgery
13.2.2.9. Breast Surgery
13.2.2.10. Ear, Nose, and Throat Surgery
13.2.2.11. Bariatric Surgery
13.2.2.12. Cosmetic/Plastic Surgery
13.2.2.13. Neurosurgery
13.2.3. Endoscopic Mucosal Resection
13.2.3.1. Thoracic Surgery
13.2.3.2. General Surgery
13.2.3.3. Cancer Surgery
13.2.3.4. Bariatric Surgery
13.2.4. Endoscopic Submucosal Dissection
13.2.4.1. General Surgery
13.2.4.2. Cancer Surgery
13.2.4.3. Bariatric Surgery
13.2.5. Transcatheter
13.2.5.1. Cardiac Surgery
13.2.5.2. Vascular Surgery
13.2.5.3. Cancer Surgery
13.2.5.4. Bariatric Surgery
13.3. Asia Pacific Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017–2031
13.3.1. Orthopedic Surgery
13.3.1.1. Knee
13.3.1.2. Spine
13.3.1.3. Shoulder
13.3.1.4. Others
13.3.2. Cardiac Surgery
13.3.2.1. Mitral Valve
13.3.2.2. Aortic Valve
13.3.2.3. Structural Heart Disease
13.3.2.4. Tricuspid Valve
13.3.2.5. Others
13.3.3. General Surgery
13.3.3.1. Gastrointestinal Surgery
13.3.3.2. Hepatobiliary Pancreatic Surgery
13.3.4. Urology Surgery
13.3.5. Thoracic Surgery
13.3.6. Gynecology Surgery
13.3.7. Vascular Surgery
13.3.8. Cancer Surgery
13.3.9. Breast Surgery
13.3.10. Ear, Nose, and Throat Surgery
13.3.11. Bariatric Surgery
13.3.12. Cosmetic/Plastic Surgery
13.3.13. Neurosurgery
13.4. Asia Pacific Minimally Invasive Surgery Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.1.1. Orthopedic Surgery
13.4.1.2. Cardiac Surgery
13.4.1.3. Thoracic Surgery
13.4.1.4. Urology Surgery
13.4.1.5. Gynecology Surgery
13.4.1.6. Vascular Surgery
13.4.1.7. General Surgery
13.4.1.8. Cancer Surgery
13.4.1.9. Breast Surgery
13.4.1.10. Ear, Nose, and Throat Surgery
13.4.1.11. Bariatric Surgery
13.4.1.12. Cosmetic/Plastic Surgery
13.4.1.13. Neurosurgery
13.4.2. Clinics
13.4.2.1. Orthopedic Surgery
13.4.2.2. Cardiac Surgery
13.4.2.3. Thoracic Surgery
13.4.2.4. Urology Surgery
13.4.2.5. Gynecology Surgery
13.4.2.6. Vascular Surgery
13.4.2.7. General Surgery
13.4.2.8. Cancer Surgery
13.4.2.9. Breast Surgery
13.4.2.10. Ear, Nose, and Throat Surgery
13.4.2.11. Bariatric Surgery
13.4.2.12. Cosmetic/Plastic Surgery
13.4.2.13. Neurosurgery
13.4.3. Ambulatory Surgical Centers
13.4.3.1. Orthopedic Surgery
13.4.3.2. Cardiac Surgery
13.4.3.3. Thoracic Surgery
13.4.3.4. Urology Surgery
13.4.3.5. Gynecology Surgery
13.4.3.6. Vascular Surgery
13.4.3.7. General Surgery
13.4.3.8. Cancer Surgery
13.4.3.9. Breast Surgery
13.4.3.10. Ear, Nose, and Throat Surgery
13.4.3.11. Bariatric Surgery
13.4.3.12. Cosmetic/Plastic Surgery
13.4.3.13. Neurosurgery
13.4.4. Others
13.4.4.1. Orthopedic Surgery
13.4.4.2. Cardiac Surgery
13.4.4.3. Thoracic Surgery
13.4.4.4. Urology Surgery
13.4.4.5. Gynecology Surgery
13.4.4.6. Vascular Surgery
13.4.4.7. General Surgery
13.4.4.8. Cancer Surgery
13.4.4.9. Breast Surgery
13.4.4.10. Ear, Nose, and Throat Surgery
13.4.4.11. Bariatric Surgery
13.4.4.12. Cosmetic/Plastic Surgery
13.4.4.13. Neurosurgery
13.5. Asia Pacific Minimally Invasive Surgery Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Japan
13.5.2. China
13.5.3. India
13.5.4. Australia & New Zealand
13.5.5. Rest of Asia Pacific
13.6. Asia Pacific Minimally Invasive Surgery Market Attractiveness Analysis
13.6.1. By Procedure
13.6.2. By Disease Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Latin America Minimally Invasive Surgery Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017–2031
14.2.1. Laparoscopic Surgery
14.2.1.1. Orthopedic Surgery
14.2.1.2. Thoracic Surgery
14.2.1.3. Urology Surgery
14.2.1.4. Gynecology Surgery
14.2.1.5. Vascular Surgery
14.2.1.6. General Surgery
14.2.1.7. Cancer Surgery
14.2.1.8. Breast Surgery
14.2.1.9. Ear, Nose, and Throat Surgery
14.2.1.10. Bariatric Surgery
14.2.2. Robotic Surgery
14.2.2.1. Orthopedic Surgery
14.2.2.2. Cardiac Surgery
14.2.2.3. Thoracic Surgery
14.2.2.4. Urology Surgery
14.2.2.5. Gynecology Surgery
14.2.2.6. Vascular Surgery
14.2.2.7. General Surgery
14.2.2.8. Cancer Surgery
14.2.2.9. Breast Surgery
14.2.2.10. Ear, Nose, and Throat Surgery
14.2.2.11. Bariatric Surgery
14.2.2.12. Cosmetic/Plastic Surgery
14.2.2.13. Neurosurgery
14.2.3. Endoscopic Mucosal Resection
14.2.3.1. Thoracic Surgery
14.2.3.2. General Surgery
14.2.3.3. Cancer Surgery
14.2.3.4. Bariatric Surgery
14.2.4. Endoscopic Submucosal Dissection
14.2.4.1. General Surgery
14.2.4.2. Cancer Surgery
14.2.4.3. Bariatric Surgery
14.2.5. Transcatheter
14.2.5.1. Cardiac Surgery
14.2.5.2. Vascular Surgery
14.2.5.3. Cancer Surgery
14.2.5.4. Bariatric Surgery
14.3. Latin America Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017–2031
14.3.1. Orthopedic Surgery
14.3.1.1. Knee
14.3.1.2. Spine
14.3.1.3. Shoulder
14.3.1.4. Others
14.3.2. Cardiac Surgery
14.3.2.1. Mitral Valve
14.3.2.2. Aortic Valve
14.3.2.3. Structural Heart Disease
14.3.2.4. Tricuspid Valve
14.3.2.5. Others
14.3.3. General Surgery
14.3.3.1. Gastrointestinal Surgery
14.3.3.2. Hepatobiliary Pancreatic Surgery
14.3.4. Urology Surgery
14.3.5. Thoracic Surgery
14.3.6. Gynecology Surgery
14.3.7. Vascular Surgery
14.3.8. Cancer Surgery
14.3.9. Breast Surgery
14.3.10. Ear, Nose, and Throat Surgery
14.3.11. Bariatric Surgery
14.3.12. Cosmetic/Plastic Surgery
14.3.13. Neurosurgery
14.4. Latin America Minimally Invasive Surgery Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.1.1. Orthopedic Surgery
14.4.1.2. Cardiac Surgery
14.4.1.3. Thoracic Surgery
14.4.1.4. Urology Surgery
14.4.1.5. Gynecology Surgery
14.4.1.6. Vascular Surgery
14.4.1.7. General Surgery
14.4.1.8. Cancer Surgery
14.4.1.9. Breast Surgery
14.4.1.10. Ear, Nose, and Throat Surgery
14.4.1.11. Bariatric Surgery
14.4.1.12. Cosmetic/Plastic Surgery
14.4.1.13. Neurosurgery
14.4.2. Clinics
14.4.2.1. Orthopedic Surgery
14.4.2.2. Cardiac Surgery
14.4.2.3. Thoracic Surgery
14.4.2.4. Urology Surgery
14.4.2.5. Gynecology Surgery
14.4.2.6. Vascular Surgery
14.4.2.7. General Surgery
14.4.2.8. Cancer Surgery
14.4.2.9. Breast Surgery
14.4.2.10. Ear, Nose, and Throat Surgery
14.4.2.11. Bariatric Surgery
14.4.2.12. Cosmetic/Plastic Surgery
14.4.2.13. Neurosurgery
14.4.3. Ambulatory Surgical Centers
14.4.3.1. Orthopedic Surgery
14.4.3.2. Cardiac Surgery
14.4.3.3. Thoracic Surgery
14.4.3.4. Urology Surgery
14.4.3.5. Gynecology Surgery
14.4.3.6. Vascular Surgery
14.4.3.7. General Surgery
14.4.3.8. Cancer Surgery
14.4.3.9. Breast Surgery
14.4.3.10. Ear, Nose, and Throat Surgery
14.4.3.11. Bariatric Surgery
14.4.3.12. Cosmetic/Plastic Surgery
14.4.3.13. Neurosurgery
14.4.4. Others
14.4.4.1. Orthopedic Surgery
14.4.4.2. Cardiac Surgery
14.4.4.3. Thoracic Surgery
14.4.4.4. Urology Surgery
14.4.4.5. Gynecology Surgery
14.4.4.6. Vascular Surgery
14.4.4.7. General Surgery
14.4.4.8. Cancer Surgery
14.4.4.9. Breast Surgery
14.4.4.10. Ear, Nose, and Throat Surgery
14.4.4.11. Bariatric Surgery
14.4.4.12. Cosmetic/Plastic Surgery
14.4.4.13. Neurosurgery
14.5. Latin America Minimally Invasive Surgery Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. Brazil
14.5.2. Mexico
14.5.3. Rest of Latin America
14.6. Latin America Minimally Invasive Surgery Market Attractiveness Analysis
14.6.1. By Procedure
14.6.2. By Disease Indication
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Middle East & Africa Minimally Invasive Surgery Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017–2031
15.2.1. Laparoscopic Surgery
15.2.1.1. Orthopedic Surgery
15.2.1.2. Thoracic Surgery
15.2.1.3. Urology Surgery
15.2.1.4. Gynecology Surgery
15.2.1.5. Vascular Surgery
15.2.1.6. General Surgery
15.2.1.7. Cancer Surgery
15.2.1.8. Breast Surgery
15.2.1.9. Ear, Nose, and Throat Surgery
15.2.1.10. Bariatric Surgery
15.2.2. Robotic Surgery
15.2.2.1. Orthopedic Surgery
15.2.2.2. Cardiac Surgery
15.2.2.3. Thoracic Surgery
15.2.2.4. Urology Surgery
15.2.2.5. Gynecology Surgery
15.2.2.6. Vascular Surgery
15.2.2.7. General Surgery
15.2.2.8. Cancer Surgery
15.2.2.9. Breast Surgery
15.2.2.10. Ear, Nose, and Throat Surgery
15.2.2.11. Bariatric Surgery
15.2.2.12. Cosmetic/Plastic Surgery
15.2.2.13. Neurosurgery
15.2.3. Endoscopic Mucosal Resection
15.2.3.1. Thoracic Surgery
15.2.3.2. General Surgery
15.2.3.3. Cancer Surgery
15.2.3.4. Bariatric Surgery
15.2.4. Endoscopic Submucosal Dissection
15.2.4.1. General Surgery
15.2.4.2. Cancer Surgery
15.2.4.3. Bariatric Surgery
15.2.5. Transcatheter
15.2.5.1. Cardiac Surgery
15.2.5.2. Vascular Surgery
15.2.5.3. Cancer Surgery
15.2.5.4. Bariatric Surgery
15.3. Middle East & Africa Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017–2031
15.3.1. Orthopedic Surgery
15.3.1.1. Knee
15.3.1.2. Spine
15.3.1.3. Shoulder
15.3.1.4. Others
15.3.2. Cardiac Surgery
15.3.2.1. Mitral Valve
15.3.2.2. Aortic Valve
15.3.2.3. Structural Heart Disease
15.3.2.4. Tricuspid Valve
15.3.2.5. Others
15.3.3. General Surgery
15.3.3.1. Gastrointestinal Surgery
15.3.3.2. Hepatobiliary Pancreatic Surgery
15.3.4. Urology Surgery
15.3.5. Thoracic Surgery
15.3.6. Gynecology Surgery
15.3.7. Vascular Surgery
15.3.8. Cancer Surgery
15.3.9. Breast Surger
15.3.10. Ear, Nose, and Throat Surgery
15.3.11. Bariatric Surgery
15.3.12. Cosmetic/Plastic Surgery
15.3.13. Neurosurgery

15.4. Middle East & Africa Minimally Invasive Surgery Market Value Forecast, by End-user, 2017–2031
15.4.1. Hospitals
15.4.1.1. Orthopedic Surgery
15.4.1.2. Cardiac Surgery
15.4.1.3. Thoracic Surgery
15.4.1.4. Urology Surgery
15.4.1.5. Gynecology Surgery
15.4.1.6. Vascular Surgery
15.4.1.7. General Surgery
15.4.1.8. Cancer Surgery
15.4.1.9. Breast Surgery
15.4.1.10. Ear, Nose, and Throat Surger
15.4.1.11. Bariatric Surgery
15.4.1.12. Cosmetic/Plastic Surgery
15.4.1.13. Neurosurgery
15.4.2. Clinics
15.4.2.1. Orthopedic Surgery
15.4.2.2. Cardiac Surgery
15.4.2.3. Thoracic Surgery
15.4.2.4. Urology Surgery
15.4.2.5. Gynecology Surgery
15.4.2.6. Vascular Surgery
15.4.2.7. General Surgery
15.4.2.8. Cancer Surgery
15.4.2.9. Breast Surgery
15.4.2.10. Ear, Nose, and Throat Surgery
15.4.2.11. Bariatric Surgery
15.4.2.12. Cosmetic/Plastic Surgery
15.4.2.13. Neurosurgery
15.4.3. Ambulatory Surgical Centers
15.4.3.1. Orthopedic Surgery
15.4.3.2. Cardiac Surgery
15.4.3.3. Thoracic Surgery
15.4.3.4. Urology Surgery
15.4.3.5. Gynecology Surgery
15.4.3.6. Vascular Surgery
15.4.3.7. General Surgery
15.4.3.8. Cancer Surgery
15.4.3.9. Breast Surgery
15.4.3.10. Ear, Nose, and Throat Surgery
15.4.3.11. Bariatric Surgery
15.4.3.12. Cosmetic/Plastic Surgery
15.4.3.13. Neurosurgery
15.4.4. Others
15.4.4.1. Orthopedic Surgery
15.4.4.2. Cardiac Surgery
15.4.4.3. Thoracic Surgery
15.4.4.4. Urology Surgery
15.4.4.5. Gynecology Surgery
15.4.4.6. Vascular Surgery
15.4.4.7. General Surgery
15.4.4.8. Cancer Surgery
15.4.4.9. Breast Surgery
15.4.4.10. Ear, Nose, and Throat Surgery
15.4.4.11. Bariatric Surgery
15.4.4.12. Cosmetic/Plastic Surgery
15.4.4.13. Neurosurgery
15.5. Middle East & Africa Minimally Invasive Surgery Market Value Forecast, by Country/Sub-region, 2017–2031
15.5.1. GCC Countries
15.5.2. South Africa
15.5.3. Rest of Middle East & Africa
15.6. Middle East & Africa Minimally Invasive Surgery Market Attractiveness Analysis
15.6.1. By Procedure
15.6.2. By Disease Indication
15.6.3. By End-user
15.6.4. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Company Profiles (Hospitals)
16.2.1. Apollo Hospitals Enterprise Limited
16.2.1.1. Services Portfolio
16.2.1.2. SWOT Analysis
16.2.1.3. Strategic Overview
16.2.2. Huntington Hospital
16.2.2.1. Services Portfolio
16.2.2.2. SWOT Analysis
16.2.2.3 Strategic Overview
16.2.3. Johns Hopkins Hospital
16.2.3.1. Services Portfolio
16.2.3.2. SWOT Analysis
16.2.3.3. Strategic Overview
16.2.4. Massachusetts General Hospital
16.2.4.1. Services Portfolio
16.2.4.2. SWOT Analysis
16.2.4.3. Strategic Overview
16.2.5. Rutland Medical Center
16.2.5.1. Services Portfolio
16.2.5.2. SWOT Analysis
16.2.5.3. Strategic Overview
16.2.6. Saint Michael's Hospital
16.2.6.1. Services Portfolio
16.2.6.2. SWOT Analysis
16.2.6.3. Strategic Overview
16.2.7. Singapore General Hospital
16.2.7.1. Services Portfolio
16.2.7.2. SWOT Analysis
16.2.7.3. Strategic Overview
16.2.8. The Ottawa Hospital
16.2.8.1. Services Portfolio
16.2.8.2. SWOT Analysis
16.2.8.3 Strategic Overview
16.2.9. University of Pittsburgh Medical Center
16.2.9.1. Services Portfolio
16.2.9.2. SWOT Analysis
16.2.9.3. Strategic Overview
16.2.10. Washington Hospital Healthcare System
16.2.10.1. Services Portfolio
16.2.10.2. SWOT Analysis
16.2.10.3. Strategic Overview
16.3. Company Profiles (Instrument Providers)
16.3.1. Abbott Laboratories
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. B. Braun Melsungen AG
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Becton, Dickinson and Company
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Boston Scientific Corporation
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. CONMED Corporation
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Johnson & Johnson Services, Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Medtronic plc
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Smith & Nephew plc
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Stryker Corporation
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Zimmer Biomet
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview